CHI3L1 and myeloid sarcoma: Increased levels of Chi3l1 in the cerebrospinal fluid (CSF) have been observed in Alzheimer’s disease (AD) and multiple sclerosis (MS) (Craig-Schapiro et al., 2010; Floro et al., 2022).